BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
4.420
-0.650 (-12.82%)
Feb 21, 2025, 4:00 PM EST - Market closed
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of $18.76 million as of February 21, 2025. Its market cap has decreased by -70.13% in one year.
Market Cap
18.76M
Enterprise Value
12.75M
1-Year Change
-70.13%
Ranking
Category
Stock Price
$4.42
Market Cap Chart
Since February 24, 2021, BriaCell Therapeutics's market cap has decreased from $26.00M to $18.76M, a decrease of -27.86%. That is a compound annual growth rate of -7.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2025 | 14.90M | -40.40% |
| Dec 31, 2024 | 25.00M | -73.26% |
| Dec 29, 2023 | 93.50M | 37.91% |
| Dec 30, 2022 | 67.80M | -46.74% |
| Dec 31, 2021 | 127.30M | 389.62% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 783.15B |
| UnitedHealth Group | 461.43B |
| Johnson & Johnson | 379.55B |
| Novo Nordisk | 365.53B |
| AbbVie | 348.46B |
| AstraZeneca | 230.61B |
| Abbott Laboratories | 228.63B |
| Intuitive Surgical | 215.88B |